Creatine and Ozempic: Safety and Kidney Function Guide

Last reviewed: May 17, 2026

Last updated: May 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, creatine can typically be taken with Ozempic, but kidney function monitoring becomes critical. GLP-1 medications increase dehydration risk, and creatine supplementation places additional stress on renal filtration—making baseline kidney assessment essential before combining them.

This question matters because many patients starting Ozempic or other GLP-1 therapies also maintain fitness routines involving creatine supplementation. PlexusDx emphasizes precision wellness: understanding your individual metabolic and renal predispositions helps your provider make safer, more personalized recommendations about supplement use during treatment.

How GLP-1 Medications Affect Hydration and Kidney Stress

GLP-1 drugs like Ozempic work partly by slowing gastric emptying, reducing appetite, and increasing satiety—which often leads to decreased fluid intake. Studies show GLP-1 users report 15–25% lower daily water consumption than baseline, increasing dehydration risk and raising serum creatinine levels.

Dehydration concentrates creatinine in the bloodstream and reduces glomerular filtration rate (GFR), the key measure of kidney function. When creatine supplementation is added to this environment, the kidneys must work harder to excrete both endogenous creatinine and exogenous creatine, potentially accelerating renal stress in susceptible individuals.

Creatine, Kidney Function, and GLP-1 Interaction Framework

Evaluating safety requires assessing baseline kidney health, current hydration patterns, and individual renal risk factors. The framework below outlines key considerations for patients considering creatine while on Ozempic or compounded GLP-1 therapies.

Consideration	Clinical Relevance
Baseline GFR or eGFR	GFR >60 mL/min/1.73m² generally supports creatine use; <45 may contraindicate it
Serum Creatinine Trend	Rising creatinine on GLP-1 alone warrants caution; may indicate dehydration or early renal stress
Daily Fluid Intake	Creatine users need 2.5–3.5 L water daily; GLP-1 therapy often reduces natural thirst cues
Electrolyte Status	GLP-1-induced nausea and reduced intake can lower sodium, potassium; creatine further concentrates urine
Concurrent Medications	NSAIDs, ACE inhibitors, or diuretics amplify renal stress risk when combined with creatine and GLP-1

Evidence on Creatine Safety in Healthy Individuals vs. GLP-1 Users

In healthy adults with normal kidney function, creatine monohydrate (3–5g daily) has a strong safety record spanning 30+ years of research. However, GLP-1 therapy creates a different physiological context: reduced hydration, potential electrolyte shifts, and baseline metabolic changes that may alter creatine metabolism.

No prospective studies directly examine creatine + GLP-1 safety. Retrospective data suggests risk is low in well-hydrated patients with GFR >60, but patients with baseline hypertension, diabetes, or family history of kidney disease should obtain baseline and quarterly renal labs (creatinine, BUN, eGFR, electrolytes) before starting creatine.

Who Should Avoid Creatine on Ozempic and Provider Guidance

Patients with eGFR <45 mL/min/1.73m², history of acute kidney injury, or uncontrolled hypertension should avoid creatine supplementation entirely while on GLP-1 therapy. Additionally, individuals who struggle to maintain adequate hydration—whether due to nausea, gastroparesis, or cognitive factors—carry higher risk and should discuss alternatives with their provider.

Before starting creatine with Ozempic or compounded GLP-1 medications, schedule a renal function panel and discuss hydration benchmarks with your healthcare team. A qualified provider can assess whether your baseline kidney health, medication regimen, and lifestyle support safe creatine use, or whether alternative supplements better suit your situation.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context around individual variations in kidney function, electrolyte handling, and metabolic stress response. Genetic predispositions in renal pathways (though not yet fully characterized in commercial testing) can support a more informed conversation with your provider about whether creatine supplementation aligns with your baseline renal reserve.

The genetic test cannot predict exact kidney response to creatine or GLP-1 medications—kidney function depends heavily on lifestyle (hydration, exercise), comorbidities (diabetes, hypertension), and medication interactions. However, understanding your metabolic predispositions should be interpreted with a qualified healthcare provider to contextualize supplement safety decisions.

If you're considering compounded GLP-1 therapy (semaglutide, tirzepatide, or microdose protocols) alongside fitness supplements, discussing your genetic and metabolic profile with a PlexusDx-affiliated provider can support a more personalized safety conversation. This approach ensures your supplement strategy aligns with your individual kidney function and GLP-1 treatment goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.